Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $709,062 - $917,922
-17,700 Reduced 61.67%
11,000 $440,000
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $532,170 - $696,420
-14,600 Reduced 33.72%
28,700 $1.37 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $1.74 Million - $2.21 Million
41,300 Added 2065.0%
43,300 $1.88 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $30,373 - $36,141
-700 Reduced 25.93%
2,000 $101,000
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $839,300 - $1.03 Million
-21,800 Reduced 88.98%
2,700 $122,000
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $52,094 - $64,995
-1,500 Reduced 5.77%
24,500 $1.01 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $359,306 - $440,840
10,700 Added 69.93%
26,000 $929,000
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $14,847 - $18,608
400 Added 2.68%
15,300 $577,000
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $248,472 - $330,888
-6,800 Reduced 31.34%
14,900 $659,000
Q2 2022

Aug 08, 2022

BUY
$31.71 - $43.0 $688,107 - $933,100
21,700 New
21,700 $803,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $373,500 - $463,000
-12,500 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $238,173 - $326,430
-9,300 Reduced 42.66%
12,500 $380,000
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $436,020 - $527,150
13,000 Added 147.73%
21,800 $731,000
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $676,984 - $926,100
-19,600 Reduced 69.01%
8,800 $351,000
Q1 2021

May 17, 2021

BUY
$42.51 - $63.78 $960,726 - $1.44 Million
22,600 Added 389.66%
28,400 $1.28 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $194,790 - $259,161
-4,300 Reduced 42.57%
5,800 $328,000
Q3 2020

Nov 16, 2020

SELL
$47.45 - $62.95 $56,940 - $75,540
-1,200 Reduced 10.62%
10,100 $479,000
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $243,620 - $317,460
-5,200 Reduced 31.52%
11,300 $666,000
Q1 2020

May 15, 2020

BUY
$41.6 - $63.4 $682,240 - $1.04 Million
16,400 Added 16400.0%
16,500 $780,000
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $285,405 - $345,931
-5,300 Reduced 98.15%
100 $6,000
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $183,086 - $223,665
-3,100 Reduced 36.47%
5,400 $324,000
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $285,614 - $396,244
4,600 Added 117.95%
8,500 $546,000
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $804,384 - $1.23 Million
-15,200 Reduced 79.58%
3,900 $317,000
Q4 2018

Feb 14, 2019

SELL
$43.37 - $59.54 $1.51 Million - $2.08 Million
-34,900 Reduced 64.63%
19,100 $1.03 Million
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $913,344 - $1.14 Million
21,300 Added 65.14%
54,000 $2.79 Million
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $1.33 Million - $1.66 Million
32,700 New
32,700 $1.36 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.